Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)
==============================================================================================================================================================================

* Michele Iuliani
* Sonia Simonetti
* Leonardo Cristofani
* Silvia Cavaliere
* Alessio Cortellini
* Marco Russano
* Bruno Vincenzi
* Giuseppe Tonini
* Daniele Santini
* Francesco Pantano